Income Statement Amicogen, Inc.

Stocks

A092040

KR7092040005

Biotechnology & Medical Research

End-of-day quote Korea S.E. 2026-10-02			5-day change	1st Jan Change
988.00 ^KRW	-0.20%		+5.67%	-44.56%

09-20	Amicogen, Inc.(KOSDAQ:A092040) dropped from S&P Global BMI Index	CI
08-14	Amicogen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

4e03cbb9cef8723e1e5a2b.dUr8TxX5AGQaTows_JWsmUqayRyGDIEA-K5f2gmmPzo.BCSGFiOvTCF4Gf5OlPHi8ADL_VLWWcVYvMkTjkbiYE0-f48Ze7V3FnIWxQ

Published financial data: AMICOGEN, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Revenues	125B	144B	160B	174B	41.98B
Other Revenues, Total	-10	-	-10	-	-
Total Revenues	125B	144B	160B	174B	41.98B
Cost of Goods Sold, Total	80.24B	98.53B	105B	123B	36.69B
Gross Profit	44.64B	45.76B	54.63B	50.21B	5.29B
Selling General & Admin Expenses, Total	33.63B	33.51B	32.99B	38.25B	11.81B
Provision for Bad Debts	158M	82.84M	1.81B	2.84B	-1.73B
R&D Expenses	10.84B	12.44B	13.78B	12.61B	7.45B
Depreciation & Amortization - (IS)	2.2B	2.4B	2.53B	3.49B	874M
Amortization of Goodwill and Intangible Assets - (IS)	927M	1.14B	1.08B	727M	1.73B
Other Operating Expenses	1.51B	1.11B	1.75B	1.86B	539M
Other Operating Expenses, Total	49.27B	50.69B	53.94B	59.77B	20.66B
Operating Income	-4.63B	-4.93B	689M	-9.56B	-15.37B
Interest Expense, Total	-2.95B	-7.46B	-11.34B	-10.24B	-7.75B
Interest And Investment Income	349M	413M	498M	534M	251M
Net Interest Expenses	-2.6B	-7.05B	-10.84B	-9.71B	-7.5B
Currency Exchange Gains (Loss)	1.23B	168M	109M	1.85B	-1.59B
Other Non Operating Income (Expenses)	4.32B	10.42B	4.47B	4.94B	-3.02B
EBT, Excl. Unusual Items	-1.67B	-1.38B	-5.57B	-12.48B	-27.49B
Impairment of Goodwill	-1.03B	-2.43B	-	-	-
Gain (Loss) On Sale Of Investments	15.2B	-45.44B	-20.96B	-38.81B	-3.51B
Gain (Loss) On Sale Of Assets	-733M	153M	-221M	3.91B	1.65B
Asset Writedown	-2.11B	-1.48B	-3.06B	-5.81M	-
Other Unusual Items	-	-	6.58B	-3.16B	-517M
EBT, Incl. Unusual Items	9.66B	-50.57B	-23.23B	-50.54B	-29.87B
Income Tax Expense	4.92B	-4.78B	-2.54B	343M	491M
Earnings From Continuing Operations	4.74B	-45.79B	-20.69B	-50.88B	-30.37B
Net Income to Company	4.74B	-45.79B	-20.69B	-50.88B	-30.37B
Minority Interest	-1.01B	-1.43B	-2.6B	-1.91B	406M
Net Income - (IS)	3.73B	-47.22B	-23.29B	-52.79B	-29.96B
Net Income to Common Incl Extra Items	3.73B	-47.22B	-23.29B	-52.79B	-29.96B
Net Income to Common Excl. Extra Items	3.73B	-47.22B	-23.29B	-52.79B	-29.96B
Per Share Items
Net EPS - Basic	96.24	-1.2K	-583.58	-960.83	-542.79
Basic EPS - Continuing Operations	96.24	-1.2K	-583.58	-960.83	-542.79
Basic Weighted Average Shares Outstanding	38.79M	39.51M	39.91M	54.94M	55.2M
Net EPS - Diluted	96	-1.2K	-583.58	-960.83	-542.79
Diluted EPS - Continuing Operations	96	-1.2K	-583.58	-960.83	-542.79
Diluted Weighted Average Shares Outstanding	38.83M	39.51M	39.91M	54.94M	55.2M
Normalized Basic EPS	-52.89	-58.04	-152.34	-176.67	-303.94
Normalized Diluted EPS	-52.84	-58.04	-152.34	-176.67	-303.94
Payout Ratio	-	-	-	-	-
Supplemental Items
EBITDA	6.14B	7.74B	13.95B	4.39B	-5.74B
EBITA	-3.69B	-3.78B	1.78B	-8.83B	-13.65B
EBIT	-4.63B	-4.93B	689M	-9.56B	-15.37B
EBITDAR	6.54B	7.95B	14.05B	4.61B	-5.61B
Effective Tax Rate - (Ratio)	50.94	9.45	10.94	-0.68	-1.64
Normalized Net Income	-2.05B	-2.29B	-6.08B	-9.71B	-16.78B
Supplemental Operating Expense Items
Advertising Expense	1.46B	2.53B	1.51B	1.83B	177M
Marketing Expenses	140M	185M	296M	367M	258M
Selling and Marketing Expenses	5.56B	12.05B	8.46B	9.99B	3.1B
General and Administrative Expenses	181M	161M	241M	184M	71.22M
Research And Development Expense From Footnotes	10.84B	12.44B	13.78B	12.61B	7.45B
Net Rental Expense, Total	398M	208M	94.82M	217M	133M
Imputed Operating Lease Interest Expense	147M	108M	58.48M	132M	76.99M
Imputed Operating Lease Depreciation	252M	99.58M	36.34M	84.97M	55.88M
Maintenance & Repair Expenses, Total	305M	277M	492M	273M	221M

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Assets
Cash And Equivalents	26.92B	20.21B	24.33B	6.1B	6.24B
Short Term Investments	15.63B	12.54B	14.22B	2.35B	1B
Total Cash And Short Term Investments	42.55B	32.75B	38.55B	8.45B	7.24B
Accounts Receivable, Total	29.85B	54.24B	57.34B	7.25B	8.6B
Other Receivables	3.1B	2.52B	4.76B	58.95B	6.44B
Notes Receivable	64.87M	2.03B	376M	150M	0
Total Receivables	33.02B	58.78B	62.47B	66.35B	15.04B
Inventory	38.71B	45.94B	46.84B	10.5B	12.94B
Prepaid Expenses	154M	355M	177M	112M	209M
Other Current Assets, Total	8.08B	6.13B	8.02B	2.46B	2.43B
Total Current Assets	123B	144B	156B	87.87B	37.86B
Gross Property Plant And Equipment	207B	246B	311B	192B	188B
Accumulated Depreciation	-67.44B	-73.08B	-82.56B	-26.54B	-33.4B
Net Property Plant And Equipment	139B	173B	228B	166B	155B
Long-term Investments	125B	92.84B	67.03B	28.42B	25.93B
Goodwill	3.69B	1.26B	1.26B	0	1.71B
Other Intangibles, Total	4.21B	1.25B	823M	592M	5.36B
Accounts Receivable Long-Term	370	-380	-240	-510	150
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	-	-	212M	14.69M	-
Deferred Charges Long-Term	13.31B	14.87B	11.68B	10.76B	4.31B
Other Long-Term Assets, Total	3.41B	2.41B	1.99B	703M	2.18B
Total Assets	411B	430B	467B	294B	232B
Liabilities
Accounts Payable, Total	35.44B	42.79B	40.66B	3.96B	5.43B
Accrued Expenses, Total	4.62B	4.75B	3.87B	3.33B	2.94B
Short-term Borrowings	71.19B	88.15B	68.44B	37.53B	22.48B
Current Portion of Long-Term Debt	4.56B	5.3B	9.34B	12.4B	16.92B
Current Portion of Leases	765M	726M	644M	534M	576M
Current Income Taxes Payable	7.76B	500M	240M	-	518M
Other Current Liabilities	36.15B	62.95B	51B	32.18B	21.2B
Total Current Liabilities	160B	205B	174B	89.93B	70.07B
Long-Term Debt	7.25B	49.73B	70.65B	68.69B	53.69B
Long-Term Leases	962M	577M	516M	820M	488M
Pension & Other Post Retirement Benefits	382M	140M	711M	1.83B	-
Deferred Tax Liability Non Current	8.12B	3.03B	1.06B	197M	192M
Other Non Current Liabilities	1.17B	1.22B	300M	313M	932M
Total Liabilities	178B	260B	247B	162B	125B
Preferred Stock Redeemable	-	-	694M	9.35B	10.64B
Total Preferred Equity	-	-	694M	9.35B	10.64B
Common Stock, Total	9.88B	9.88B	27.35B	27.51B	27.87B
Additional Paid In Capital	85.61B	85.7B	137B	139B	142B
Retained Earnings	98.28B	51.28B	27.81B	-38.64B	-71.08B
Treasury Stock	-5B	-5B	-5B	-5B	-5B
Comprehensive Income and Other	-2.6B	-10.07B	-11.67B	-853M	591M
Total Common Equity	186B	132B	176B	122B	94.57B
Minority Interest	46.71B	37.98B	43.13B	602M	1.29B
Total Equity	233B	170B	220B	132B	106B
Total Liabilities And Equity	411B	430B	467B	294B	232B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	39.1M	39.11M	54.51M	54.82M	55.53M
ECS Total Common Shares Outstanding	39.1M	39.11M	54.51M	54.82M	55.53M
Book Value / Share	4.76K	3.37K	3.23K	2.23K	1.7K
Tangible Book Value	178B	129B	174B	122B	87.5B
Tangible Book Value Per Share	4.56K	3.31K	3.19K	2.22K	1.58K
Total Debt	84.72B	144B	150B	120B	94.15B
Net Debt	42.18B	112B	111B	112B	86.91B
Debt Equivalent Oper. Leases	3.19B	1.66B	759M	1.73B	1.06B
Minority Interest, Total (Incl. Fin. Div)	46.71B	37.98B	43.13B	602M	1.29B
Equity Method Investments, Total	91.57B	74B	59.95B	28.3B	25.93B
Inventories - Raw Materials, Total	13.24B	14.87B	10.55B	5.08B	5.57B
Inventories - Work In Process, Total	3.69B	2.67B	2.12B	620M	2.3B
Inventories - Finished Goods, Total	23.13B	30.56B	36.15B	6.37B	7.95B
Inventories - Others	300	1.64K	480	850	-
Land - (BS)	20.94B	21.34B	21.52B	18.9B	16.41B
Buildings, Total	38.46B	52.68B	55.32B	103B	103B
Machinery, Total	103B	114B	119B	59.23B	59.59B
Accumulated Allowance for Doubtful Accounts (Supple)	754M	718M	803M	246M	276M

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Net Income	3.73B	-47.22B	-23.29B	-52.79B	-29.96B
Depreciation & Amortization - CF	9.84B	11.52B	12.18B	13.22B	7.9B
Amortization of Goodwill and Intangible Assets - (CF)	935M	1.15B	1.09B	731M	1.73B
Depreciation & Amortization, Total	10.77B	12.67B	13.26B	13.95B	9.63B
(Gain) Loss From Sale Of Asset	732M	-153M	221M	-3.91B	-1.65B
(Gain) Loss on Sale of Investments - (CF)	-22.59B	21.95B	1.72B	3.24B	984M
Asset Writedown & Restructuring Costs	3.13B	3.9B	3.06B	-	2.88B
(Income) Loss On Equity Investments - (CF)	7.39B	23.49B	19.24B	35.58B	2.53B
Stock-Based Compensation (CF)	1.15B	761M	597M	392M	356M
Provision and Write-off of Bad Debts	126M	43.85M	433M	200M	-2B
Other Operating Activities, Total	2.16B	-12.89B	1.51B	8.14B	7.11B
Change In Accounts Receivable	-1.94B	-31.1B	-3.39B	-1.37B	2.5B
Change In Inventories	-1.76B	-8.76B	-1.26B	-9.26B	-4.63B
Change In Accounts Payable	5.61B	14.37B	104M	13.59B	-1.79B
Change In Income Taxes	-247M	-13.71M	44.64M	-197M	2.18M
Change in Other Net Operating Assets	-203M	544M	-3.62B	-20.9B	-10.4B
Cash from Operations	8.07B	-22.41B	8.64B	-13.34B	-24.42B
Capital Expenditure	-47.31B	-45.91B	-62.52B	-47.68B	-3.71B
Sale of Property, Plant, and Equipment	12M	93.58M	74.67M	4.94B	2.34B
Cash Acquisitions	-	-17B	-	-	-
Divestitures	-	-	-	-	55.96B
Sale (Purchase) of Intangible assets	-9.89B	-1.41B	-87.64M	-2.14B	-63.25M
Investment in Marketable and Equity Securities, Total	-41.37B	-8.53B	1.85B	36.72B	1.53B
Net (Increase) Decrease in Loans Originated / Sold - Investing	561M	-2.18B	632M	-3.33B	15.81B
Other Investing Activities, Total	-557M	2.48B	1.78B	-12.2B	1.69B
Cash from Investing	-98.55B	-72.45B	-58.26B	-23.68B	73.55B
Short Term Debt Issued, Total	40.38B	24.47B	51.96B	67.8B	987M
Long-Term Debt Issued, Total	54.58B	93.1B	30.72B	38.59B	7B
Total Debt Issued	94.97B	118B	82.68B	106B	7.99B
Short Term Debt Repaid, Total	-34.1B	-27.5B	-43.04B	-52.67B	-37.01B
Long-Term Debt Repaid, Total	-1.8B	-2.3B	-56.16B	-52.31B	-18.9B
Total Debt Repaid	-35.9B	-29.8B	-99.2B	-105B	-55.91B
Issuance of Common Stock	22.42B	66.26M	70.3B	-	-
Repurchase of Common Stock	-	-	-	-	-
Issuance of Preferred Stock	1.5B	-	-	14.8B	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Other Financing Activities, Total	993M	1.82B	405M	364M	-5.07M
Cash from Financing	83.98B	89.65B	54.18B	16.58B	-47.93B
Foreign Exchange Rate Adjustments	2.61B	-1.49B	-440M	2.21B	11.27M
Miscellaneous Cash Flow Adjustments	10	10	-	10	-1.07B
Net Change in Cash	-3.89B	-6.71B	4.12B	-18.23B	137M
Supplemental Items
Cash Interest Paid	1.27B	1.83B	2.74B	4.43B	5.06B
Cash Income Tax Paid (Refund)	2.96B	8.08B	-319M	1.06B	-32.83M
Levered Free Cash Flow	-15.86B	-46.59B	-77.54B	-66.45B	30.83B
Unlevered Free Cash Flow	-14.02B	-41.93B	-70.45B	-60.05B	35.68B
Change In Net Working Capital	-35.3B	4.19B	21.54B	18.21B	-39.43B
Net Debt Issued / Repaid	59.07B	87.76B	-16.53B	1.41B	-47.92B

Fiscal Period: December	2021 (KRW)	2022 (KRW)	2023 (KRW)	2024 (KRW)	2025 (KRW)
Profitability
Return on Assets	-0.83	-0.73	0.1	-1.57	-3.65
Return on Total Capital	-1.04	-0.97	0.13	-1.92	-4.24
Return On Equity %	2.23	-22.74	-10.63	-28.9	-25.42
Return on Common Equity	2.2	-29.7	-15.14	-35.39	-27.6
Margin Analysis
Gross Profit Margin %	35.75	31.71	34.17	28.92	12.6
SG&A Margin	26.93	23.23	20.63	22.03	28.14
EBITDA Margin %	4.92	5.36	8.73	2.53	-13.68
EBITA Margin %	-2.96	-2.62	1.11	-5.09	-32.51
EBIT Margin %	-3.71	-3.41	0.43	-5.51	-36.62
Income From Continuing Operations Margin %	3.8	-31.73	-12.94	-29.31	-72.33
Net Income Margin %	2.99	-32.72	-14.56	-30.41	-71.36
Net Avail. For Common Margin %	2.99	-32.72	-14.56	-30.41	-71.36
Normalized Net Income Margin	-1.64	-1.59	-3.8	-5.59	-39.96
Levered Free Cash Flow Margin	-12.7	-32.29	-48.49	-38.28	73.44
Unlevered Free Cash Flow Margin	-11.23	-29.06	-44.06	-34.59	84.99
Asset Turnover
Asset Turnover	0.36	0.34	0.36	0.46	0.16
Fixed Assets Turnover	1.1	0.92	0.8	0.88	0.26
Receivables Turnover (Average Receivables)	5.52	3.43	2.87	5.38	5.3
Inventory Turnover (Average Inventory)	2.17	2.33	2.27	4.3	3.13
Short Term Liquidity
Current Ratio	0.76	0.7	0.9	0.98	0.54
Quick Ratio	0.47	0.44	0.58	0.83	0.32
Operating Cash Flow to Current Liabilities	0.05	-0.11	0.05	-0.15	-0.35
Days Sales Outstanding (Average Receivables)	66.18	106.36	127.34	68.08	68.89
Days Outstanding Inventory (Average Inventory)	168.36	156.78	160.84	85.03	116.58
Average Days Payable Outstanding	112.58	135	143.45	93.8	43.82
Cash Conversion Cycle (Average Days)	121.96	128.14	144.73	59.31	141.65
Long Term Solvency
Total Debt/Equity	36.38	85.1	68.1	90.58	88.4
Total Debt / Total Capital	26.68	45.97	40.51	47.53	46.92
LT Debt/Equity	3.53	29.63	32.4	52.48	50.87
Long-Term Debt / Total Capital	2.59	16.01	19.27	27.54	27
Total Liabilities / Total Assets	43.37	60.48	52.97	54.98	54.07
EBIT / Interest Expense	-1.57	-0.66	0.06	-0.93	-1.98
EBITDA / Interest Expense	2.08	1.04	1.23	0.43	-0.74
(EBITDA - Capex) / Interest Expense	-13.96	-5.12	-4.28	-4.23	-1.22
Total Debt / EBITDA	13.79	18.67	10.72	27.32	-16.39
Net Debt / EBITDA	6.87	14.44	7.96	25.4	-15.13
Total Debt / (EBITDA - Capex)	-2.06	-3.79	-3.08	-2.77	-9.96
Net Debt / (EBITDA - Capex)	-1.02	-2.93	-2.29	-2.58	-9.19
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	7.79	15.55	10.82	8.57	-75.82
Gross Profit, 1 Yr. Growth %	0.21	2.51	19.39	-8.1	-89.46
EBITDA, 1 Yr. Growth %	-51.42	25.97	80.3	-68.53	-230.83
EBITA, 1 Yr. Growth %	-205.88	2.36	-146.97	-597.48	54.5
EBIT, 1 Yr. Growth %	-274.97	6.45	-114	-1.49K	60.77
Earnings From Cont. Operations, 1 Yr. Growth %	-85.32	-1.07K	-54.82	145.93	-40.32
Net Income, 1 Yr. Growth %	-88.19	-1.37K	-50.68	126.68	-43.25
Normalized Net Income, 1 Yr. Growth %	722.98	11.78	165.11	59.66	72.83
Diluted EPS Before Extra, 1 Yr. Growth %	-88.32	-1.34K	-51.67	64.64	-43.52
Accounts Receivable, 1 Yr. Growth %	93.5	81.67	5.72	-87.35	18.52
Inventory, 1 Yr. Growth %	9.62	18.67	1.96	-77.59	23.31
Net Property, Plant and Equip., 1 Yr. Growth %	58.17	24.29	31.75	-27.27	-6.84
Total Assets, 1 Yr. Growth %	45.12	4.48	8.72	-37.01	-21.2
Tangible Book Value, 1 Yr. Growth %	28.87	-27.48	34.4	-29.84	-28.22
Common Equity, 1 Yr. Growth %	21.72	-29.2	33.42	-30.34	-22.8
Cash From Operations, 1 Yr. Growth %	-8.94	-377.61	-138.56	-254.29	83.16
Capital Expenditures, 1 Yr. Growth %	241.51	-2.96	36.13	-23.73	-92.22
Levered Free Cash Flow, 1 Yr. Growth %	328.9	193.71	66.37	-14.3	-146.4
Unlevered Free Cash Flow, 1 Yr. Growth %	391.74	199.06	67.97	-14.77	-159.42
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	4.13	11.6	13.16	9.69	-48.76
Gross Profit, 2 Yr. CAGR %	-3.79	1.35	10.63	4.75	-68.88
EBITDA, 2 Yr. CAGR %	-9.27	-21.77	50.71	-24.68	-35.84
EBITA, 2 Yr. CAGR %	33.2	4.11	-30.66	52.87	177.24
EBIT, 2 Yr. CAGR %	33.65	36.48	-61.4	39.33	372.23
Earnings From Cont. Operations, 2 Yr. CAGR %	347.24	19.08	108.91	5.41	21.15
Net Income, 2 Yr. CAGR %	556.07	22.23	149.78	5.73	13.42
Normalized Net Income, 2 Yr. CAGR %	1.04K	203.31	72.15	105.74	66.12
Diluted EPS Before Extra, 2 Yr. CAGR %	551.99	20.58	146.56	-10.8	-3.56
Accounts Receivable, 2 Yr. CAGR %	22.98	87.49	38.58	-63.43	-61.28
Inventory, 2 Yr. CAGR %	7.71	14.05	10	-52.2	-47.43
Net Property, Plant and Equip., 2 Yr. CAGR %	27.88	40.21	27.97	-2.11	-17.68
Total Assets, 2 Yr. CAGR %	30.52	23.14	6.58	-17.25	-29.54
Tangible Book Value, 2 Yr. CAGR %	27.63	-3.32	-1.27	-2.9	-29.04
Common Equity, 2 Yr. CAGR %	23.5	-7.17	-2.81	-3.59	-26.67
Cash From Operations, 2 Yr. CAGR %	-4	59	3.47	-22.87	68.11
Capital Expenditures, 2 Yr. CAGR %	56.73	82.04	14.95	1.89	-75.65
Levered Free Cash Flow, 2 Yr. CAGR %	16.55	254.92	121.09	19.4	-36.94
Unlevered Free Cash Flow, 2 Yr. CAGR %	13.51	283.48	124.17	19.65	-28.84
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.73	7.8	11.34	11.61	-33.74
Gross Profit, 3 Yr. CAGR %	13.91	-1.74	7.04	4	-51.29
EBITDA, 3 Yr. CAGR %	-15.6	1.22	3.34	-10.59	-9.46
EBITA, 3 Yr. CAGR %	11.5	22.01	-20.15	33.74	53.41
EBIT, 3 Yr. CAGR %	27.64	23.89	-36.12	27.38	46.14
Earnings From Cont. Operations, 3 Yr. CAGR %	-51.46	478.11	-13.79	120.59	-12.8
Net Income, 3 Yr. CAGR %	-54.71	716.59	-9.68	141.83	-14.07
Normalized Net Income, 3 Yr. CAGR %	85.45	425.98	190	67.88	94.13
Diluted EPS Before Extra, 3 Yr. CAGR %	-54.89	708.87	-10.79	115.51	-23.4
Accounts Receivable, 3 Yr. CAGR %	35.31	40.06	54.89	-37.6	-45.88
Inventory, 3 Yr. CAGR %	4.73	11.25	9.87	-35.28	-34.44
Net Property, Plant and Equip., 3 Yr. CAGR %	20.32	26.67	37.33	6	-3.71
Total Assets, 3 Yr. CAGR %	21.16	21.19	18.13	-10.56	-18.58
Tangible Book Value, 3 Yr. CAGR %	15.89	5.72	7.9	-11.9	-12.2
Common Equity, 3 Yr. CAGR %	13.51	2.59	4.76	-13.02	-10.47
Cash From Operations, 3 Yr. CAGR %	41.66	36.77	-0.85	18.21	2.91
Capital Expenditures, 3 Yr. CAGR %	63.21	33.58	65.25	0.26	-56.78
Levered Free Cash Flow, 3 Yr. CAGR %	8.17	58.6	175.74	61.2	-12.87
Unlevered Free Cash Flow, 3 Yr. CAGR %	5.8	56.78	191.27	62.4	-5.25
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	12.61	14.39	11.09	8.55	-18.37
Gross Profit, 5 Yr. CAGR %	13.65	13.28	12.58	0.81	-34.7
EBITDA, 5 Yr. CAGR %	-8.26	-5.01	6.43	-10.07	-14.6
EBITA, 5 Yr. CAGR %	-4.63	4.06	-7.79	33.52	31.37
EBIT, 5 Yr. CAGR %	2.07	21.05	-20.89	29.85	42.2
Earnings From Cont. Operations, 5 Yr. CAGR %	20.03	66.53	-12.97	192.66	-1.22
Net Income, 5 Yr. CAGR %	18.63	59.28	-10.33	260.49	-1.06
Normalized Net Income, 5 Yr. CAGR %	1.4	33.71	80.01	261.33	132.06
Diluted EPS Before Extra, 5 Yr. CAGR %	17.15	37.07	-11.01	235.56	-7.97
Accounts Receivable, 5 Yr. CAGR %	11.43	33.23	36.61	-18.15	-11.04
Inventory, 5 Yr. CAGR %	15.65	11.47	6.81	-20.65	-18.19
Net Property, Plant and Equip., 5 Yr. CAGR %	17.11	21.72	23.32	14.27	11.91
Total Assets, 5 Yr. CAGR %	22.96	21.31	15.1	4.04	-3.93
Tangible Book Value, 5 Yr. CAGR %	21.38	11.27	8.7	2.18	-8.75
Common Equity, 5 Yr. CAGR %	17.95	8.12	6.68	0.07	-9.17
Cash From Operations, 5 Yr. CAGR %	-6.47	13.53	24.93	8.77	22.47
Capital Expenditures, 5 Yr. CAGR %	27.89	32.01	41.86	19.88	-23.17
Levered Free Cash Flow, 5 Yr. CAGR %	20.59	48.81	43.97	41.59	52.83
Unlevered Free Cash Flow, 5 Yr. CAGR %	20	48.64	42.86	40.72	65.76